Credit Suisse Group started coverage on shares of Cigna Corporation (NYSE:CI) in a research report released on Thursday. The brokerage issued an outperform rating and a $219.00 price target on the health services provider’s stock.

Other equities analysts have also issued reports about the stock. Deutsche Bank AG lifted their price objective on shares of Cigna Corporation from $175.00 to $180.00 and gave the company a buy rating in a research report on Thursday, July 13th. Royal Bank Of Canada restated a buy rating and set a $182.00 target price on shares of Cigna Corporation in a research report on Monday, July 24th. BidaskClub upgraded shares of Cigna Corporation from a buy rating to a strong-buy rating in a research report on Friday, August 18th. Piper Jaffray Companies restated a buy rating and set a $191.00 target price on shares of Cigna Corporation in a research report on Sunday, September 17th. Finally, Citigroup Inc. boosted their target price on shares of Cigna Corporation from $185.00 to $198.00 and gave the stock a buy rating in a research report on Monday, August 7th. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of $201.50.

Cigna Corporation (CI) traded up $3.51 during mid-day trading on Thursday, reaching $201.90. 1,238,151 shares of the company’s stock were exchanged, compared to its average volume of 1,508,257. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.32. The company has a market cap of $49,778.45, a price-to-earnings ratio of 19.45, a PEG ratio of 1.49 and a beta of 0.49.

Cigna Corporation (NYSE:CI) last announced its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. The business had revenue of $10.38 billion for the quarter, compared to analysts’ expectations of $10.17 billion. Cigna Corporation had a net margin of 5.74% and a return on equity of 18.85%. The company’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.94 EPS. sell-side analysts predict that Cigna Corporation will post 10.39 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Credit Suisse Group Begins Coverage on Cigna Corporation (CI)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/credit-suisse-group-begins-coverage-on-cigna-corporation-ci/1681012.html.

In other Cigna Corporation news, Director William D. Zollars sold 1,232 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total value of $230,667.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Mary T. Hoeltzel sold 525 shares of the company’s stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $177.59, for a total value of $93,234.75. Following the completion of the transaction, the vice president now owns 1,924 shares of the company’s stock, valued at approximately $341,683.16. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,696 shares of company stock valued at $8,070,481. 1.30% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CI. JPMorgan Chase & Co. boosted its holdings in Cigna Corporation by 40.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock worth $684,413,000 after acquiring an additional 1,184,632 shares during the period. Waddell & Reed Financial Inc. boosted its stake in shares of Cigna Corporation by 125.8% during the 1st quarter. Waddell & Reed Financial Inc. now owns 1,749,647 shares of the health services provider’s stock valued at $256,306,000 after buying an additional 974,747 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Cigna Corporation by 221.8% during the 1st quarter. AQR Capital Management LLC now owns 926,328 shares of the health services provider’s stock valued at $135,698,000 after buying an additional 638,426 shares during the last quarter. FMR LLC boosted its stake in shares of Cigna Corporation by 6.7% during the 2nd quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after buying an additional 432,978 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of Cigna Corporation by 4,082.8% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock valued at $73,355,000 after buying an additional 427,754 shares during the last quarter. Hedge funds and other institutional investors own 88.23% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.